Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "In-vitro Toxicology Testing Market Size, Share & Trends Analysis Report By Technology (Cell Culture, High Throughput), By Method, By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global in-vitro toxicology testing market size is projected to reach USD 64.7 billion by 2030, at a CAGR of 11.10% over the forecast period.
Companies Mentioned
- Charles River Laboratories International, Inc.
- Thermo Fisher Scientific, Inc.
- Abbott Laboratories
- SGS S.A.
- Laboratory Corporation Of America Holdings
- Merck Kgaa
- Eurofins Scientific
- Evotec S.E.
- Agilent Technolgies, Inc.
- Quest Diagnostics Incorporated
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Catalent, Inc.
- Bioivt
- Gentronix
Over the years, acceptance of in-vitro toxicology testing methods by regulatory authorities is increasing at a faster pace & thus validation of these tests methods opposed to conventional testing is even rising.
Also, development of technologies to substitute animal use for toxicology tests has fueled the usage of in-vitro models such as in-silico simulation, assays, 3D cell cultures and many more, thereby boosting market growth.
Screening of a new drug candidate involves the use of animals for preclinical studies which is very tedious and expensive. However, in recent times, several jurisdictions are promoting ban for animal-based chemical testing.
For example, for several years, the EU has been promoting the reduction, replacement, and refinement of animal tests. The Regulation on cosmetic products (1223/2009), REACH (2007/2006), the Directive on the protection of animals used for scientific purposes (2010/63), and Classification, Labelling and Packaging (CLP) (1272/2008) are some examples of EU legislation that are engaged in strongly encouraging the replacement of animal toxicology testing.
Furthermore, in June 2018, the Cruelty-Free Cosmetics Act was passed in California to ban the selling of animal-tested products after 2020.
Many governments and private organization are taking actions to minimize conventional testing models, providing funds to support & develop in-vitro toxicology assays and form conducive government policies.
Thus, increase in government initiatives that are focused on banning animal testing can be attributed to the rise in adoption of in-vitro toxicological models and creates many opportunities within the market. For instance, approximately USD 3.2 million were contributed by People for the Ethical Treatment of Animals (PETA) and its international associates to promote the development of non-animal test methods.
The advancements in computational and screening methods such as biological, high throughput, and chemical coupled with the vast number of public databases for toxicity analysis has expanded largely. This has allowed researchers to access information for drug discovery studies, toxicology profiling, and drug development programs. For instance, the MetaTox HS project by Agilent Technologies, Inc. brings advanced solutions for toxicity assays & high sensitivity metabolism during drug development procedures.
In-vitro Toxicology Testing Market Report Highlights
- Based on technology, the cell culture segment held the largest revenue share in 2022, owing to the increased demand for accurate & cost-effective analysis. Moreover, the adoption of 3D cell culture is also propelling the growth of this segment
- On basis of application, the system toxicology segment dominated the market for in-vitro toxicology testing in 2022. Generation of toxicology data points such as minimum dose, tolerated dose, risk assessment and many more will contribute to the revenue generation
- The cellular assays segment accounted for the highest revenue share in 2022, owing to the developments in cell-based imaging assays, high throughput screening & label-free detection
- The pharmaceutical industry as an end-user contributed the largest revenue to the market in 2022. The importance of toxicology testing during drug development stages coupled with high number of product pipeline attributes to the revenue generation
- North America accounted for the highest revenue share in 2022 due to prevalence of animal testing bans & supportive government initiatives for toxicology research. In addition, aggregation of players in this regions to provide in-vitro testing product and services will continue the revenue generation during the forecast
Report Metrics:
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $30955.5 Million |
| Forecasted Market Value (USD) by 2030 | $64700 Million |
| Compound Annual Growth Rate | 11.1% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.2 In-vitro Toxicology Testing Market: Cost Structure Analysis
3.3 Market Trends & Outlook
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Rise In Government Funding For Toxicology Research
3.4.1.2 Opposition To Animal Testing
3.4.1.3 Ongoing Developments To Adavnce Toxicology Research
3.4.2 Market Restraint Analysis
3.4.2.1 Lack of in-vitro models
3.4.2.2 Issues pertaining to standarization of in-vitro studies
3.5 Penetration &Growth Prospect Mapping, 2022
3.6 In-vitro Toxicology Testing Market - Porter's Analysis
3.7 In-vitro Toxicology Testing Market - SWOT Analysis
3.8 COVID-19 Impact Analysis
Chapter 4 End-user Business Analysis
4.1 In-vitro Toxicology Testing Market: End-user Movement Analysis
4.2 Pharmaceutical Industry
4.2.1 In-Vitro Toxicology Market For Pharmaceutical Industry, 2018 - 2030 (USD Million)
4.3 Cosmetics & Household Products
4.3.1 In-Vitro Toxicology Market For Cosmetics And Household Products, 2018 - 2030 (USD Million)
4.4 Academic Institutes & Research Laboratories
4.4.1 In-Vitro Toxicology Market For Academic Institutes & Research Laboratories, 2018 - 2030 (USD Million)
4.5 Diagnostics
4.5.1 In-Vitro Toxicology Market For Diagnostics, 2018 - 2030 (USD Million)
4.6 Chemicals Industry
4.6.1 In-Vitro Toxicology Market For Chemicals Industry, 2018 - 2030 (USD Million)
4.7 Food Industry
4.7.1 In-Vitro Toxicology Market For Food Industry, 2018 - 2030 (USD Million)
Chapter 5 Technology Business Analysis
5.1 Global In Vitro Toxicology Testing Market: Technology Movement Analysis
5.2 Cell Culture Technology
5.2.1 In-Vitro Toxicology Market For Cell Culture Technology, 2018 - 2030 (USD Million)
5.3 High-Throughput Technology (Htt)
5.3.1 In-Vitro Toxicology Market For Htt, 2018 - 2030 (USD Million)
5.4 Molecular Imaging
5.4.1 In-Vitro Toxicology Market For Molecular Imaging, 2018 - 2030 (USD Million)
5.5 Omics Technology
5.5.1 In-Vitro Toxicology Market For Omics Technology, 2018 - 2030 (USD Million)
Chapter 6 Application Business Analysis
6.1 In-Vitro Toxicology Testing Market: Application Movement Analysis
6.2 Systemic Toxicology
6.2.1 In-Vitro Toxicology Market For Systemic Toxicology, 2018 - 2030 (USD Million)
6.3 Dermal Toxicity
6.3.1 In-Vitro Toxicology Market For Dermal Toxicity, 2018 - 2030 (USD Million)
6.4 Endocrine Disruption
6.4.1 In-Vitro Toxicology Market For Endocrine Disruption, 2018 - 2030 (USD Million)
6.5 Ocular Toxicity
6.5.1 In-Vitro Toxicology Market For Ocular Toxicity, 2018 - 2030 (USD Million)
6.6 Other Applications
6.6.1 In-Vitro Toxicology Market For Other Applications, 2018 - 2030 (USD Million)
Chapter 7 Method Business Analysis
7.1 Global In Vitro Toxicology Testing Market: Method Movement Analysis
7.2 Cellular Assays
7.2.1 In-Vitro Toxicology Market For Cellular Assay, 2018 - 2030 (USD Million)
7.2.2 Live Cells
7.2.2.1 In-vitro toxicology market for live cells, 2018 - 2030 (USD Million)
7.2.2.2 High throughput / high content screening
7.2.2.2.1 High throughput / high content screening market for live cell-based in-vitro toxicology testing, 2018 - 2030 (USD Million)
7.2.2.3 Molecular imaging
7.2.2.3.1 Molecular imaging market for live cell-based in-vitro toxicology testing, 2018 - 2030 (USD Million)
7.2.2.3.2 Confocal microscopy
7.2.2.3.2.1 Confocal microscopy market for live cell-based in-vitro toxicology testing, 2018 - 2030 (USD Million)
7.2.2.3.3 Other molecular imaging technique
7.2.2.3.3.1 Other molecular imaging technique market for live cell-based in-vitro toxicology testing, 2018 - 2030 (USD Million)
7.2.2.4 Others
7.2.2.4.1 Live cell-based in-vitro toxicology testing market for other technologies, 2018 - 2030 (USD Million)
7.2.3 Fixed Cells
7.2.3.1 Fixed cell-based in-vitro toxicology testing market, 2018 - 2030 (USD Million)
7.3 Biochemical Assays
7.3.1 Biochemical Assays Market For In Vitro Toxicology Testing, 2018 - 2030 (USD Million)
7.4 In Silico
7.4.1 In Silico Assays Market For In Vitro Toxicology Testing, 2018 - 2030 (USD Million)
7.5 Ex Vivo
7.5.1 Ex Vivo Assays Market For In Vitro Toxicology Testing, 2018 - 2030 (USD Million)
Chapter 8 In-Vitro Toxicology Testing Market: Regional Business Analysis
Chapter 9 Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/r/6e8rkv-vitro?w=12
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
